| 臺大學術典藏 |
2020-07-15T04:53:23Z |
Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection
|
Wu, U. I.; Chuang, Y. C.; Sheng, W. H.; Sun, H. Y.; Jhong, Y. T.; Wang, J. Y.; Chang, S. C.; Wang, J. T.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-07-15T04:39:17Z |
Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies
|
YEE-CHUN CHEN; Chang, S. C.; Hsu, L. Y.; Cheng, A.; Sun, H. Y.; Sheng, W. H.; Wu, U. I.; Wang, J. T. |
| 臺大學術典藏 |
2020-07-14T08:57:18Z |
Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies
|
Wu, U. I.; Wang, J. T.; Sheng, W. H.; Sun, H. Y.; Cheng, A.; Hsu, L. Y.; Chang, S. C.; Chen ,Y.C |
| 臺大學術典藏 |
2020-07-03T08:45:41Z |
TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
|
Lai H.-H;Li C.-W;Hong C.-C;Sun H.-Y;Chiu C.-F;Da-Liang Ou;Chen P.-S.; Lai H.-H; Li C.-W; Hong C.-C; Sun H.-Y; Chiu C.-F; DA-LIANG OU; Chen P.-S. |
| 臺大學術典藏 |
2020-07-03T02:18:26Z |
Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan
|
Chang S.-Y.;Chen M.-Y.;Lee C.-N.;Sun H.-Y.;Ko W.;Chang S.-F.;Chang K.-L.;Hsieh S.-M.;Sheng W.-H.;Liu W.-C.;Wu C.-H.;Chuan-Liang Kao;Hung C.-C.;Chang S.-C.; Chang S.-Y.; Chen M.-Y.; Lee C.-N.; Sun H.-Y.; Ko W.; Chang S.-F.; Chang K.-L.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Wu C.-H.; CHUAN-LIANG KAO; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-30T06:13:43Z |
Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection [6]
|
Sun H.-Y.;Tseng S.-P.;Hsueh P.-R.;Hung C.-C.;Hsieh S.-M.;Lee-Jene Teng;Ho S.-W.; Sun H.-Y.; Tseng S.-P.; Hsueh P.-R.; Hung C.-C.; Hsieh S.-M.; LEE-JENE TENG; Ho S.-W. |
| 臺大學術典藏 |
2020-06-18T08:26:22Z |
Clinical presentations and virologic characteristics of primary human immunodeficiency virus type-1 infection in a university hospital in Taiwan
|
Sun H.-Y.;Chen M.-J.;Hung C.-C.;Chen M.-Y.;Hsieh S.-M.;Sheng W.-H.;Fang C.-T.;Sui-Yuan Chang;Chang S.-C.; Sun H.-Y.; Chen M.-J.; Hung C.-C.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Fang C.-T.; SUI-YUAN CHANG; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:26:21Z |
Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan
|
Chang S.-C.;Sun H.-Y.;Sheng W.-H.;SUI-YUAN CHANG;Hsieh S.-M.;Chen M.-Y.;Hsiao C.-F.;Hung C.-C.; Hung C.-C.; Hsiao C.-F.; Chen M.-Y.; Hsieh S.-M.; SUI-YUAN CHANG; Sheng W.-H.; Sun H.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:26:20Z |
Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
|
Hung C.C.;Hung M.N.;Hsueh P.R.;Sui-Yuan Chang;Chen M.Y.;Hsieh S.M.;Sheng W.H.;Sun H.Y.;Huang Y.T.;Lo Y.C.;Hsiao C.F.;Chang S.C.; Hung C.C.; Hung M.N.; Hsueh P.R.; SUI-YUAN CHANG; Chen M.Y.; Hsieh S.M.; Sheng W.H.; Sun H.Y.; Huang Y.T.; Lo Y.C.; Hsiao C.F.; Chang S.C. |
| 臺大學術典藏 |
2020-06-18T08:26:19Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng W.-H.;Kao J.-H.;Chen P.-J.;Huang L.-M.;Sui-Yuan Chang;Sun H.-Y.;Hung C.-C.;Chen M.-Y.;Chang S.-C.; Sheng W.-H.; Kao J.-H.; Chen P.-J.; Huang L.-M.; SUI-YUAN CHANG; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:26:18Z |
Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan
|
Sun H.-Y.;Hung C.-C.;Lin P.-H.;Chang S.-F.;Yang C.-Y.;Sui-Yuan Chang;Chang S.-C.; Sun H.-Y.; Hung C.-C.; Lin P.-H.; Chang S.-F.; Yang C.-Y.; SUI-YUAN CHANG; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:26:17Z |
Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital
|
Liang S.-H.;Lo Y.-C.;Lin H.-H.;Sui-Yuan Chang;Chen M.-Y.;Hsieh S.-M.;Sheng W.-H.;Sun H.-Y.;Hung C.-C.;Chang S.-C.; Liang S.-H.; Lo Y.-C.; Lin H.-H.; SUI-YUAN CHANG; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Sun H.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:26:17Z |
Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan
|
Sui-Yuan Chang;Chen M.-Y.;Lee C.-N.;Sun H.-Y.;Ko W.;Chang S.-F.;Chang K.-L.;Hsieh S.-M.;Sheng W.-H.;Liu W.-C.;Wu C.-H.;Kao C.-L.;Hung C.-C.;Chang S.-C.; SUI-YUAN CHANG; Chen M.-Y.; Lee C.-N.; Sun H.-Y.; Ko W.; Chang S.-F.; Chang K.-L.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Wu C.-H.; Kao C.-L.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:26:13Z |
Amebiasis among persons who sought voluntary counseling and testing for human immunodeficiency virus infection: A case-control study
|
Hung C.-C.;Wu P.-Y.;Sui-Yuan Chang;Ji D.-D.;Sun H.-Y.;Liu W.-C.;Wu C.-H.;Chang S.-C.; Hung C.-C.; Wu P.-Y.; SUI-YUAN CHANG; Ji D.-D.; Sun H.-Y.; Liu W.-C.; Wu C.-H.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:26:10Z |
Risk and incidence of pulmonary diseases among HIV-infected patients in the era of combination antiretroviral therapy
|
Hung C.-C.;Sui-Yuan Chang;Lee K.-Y.;Sun H.-Y.;Lu C.-L.; Hung C.-C.; SUI-YUAN CHANG; Lee K.-Y.; Sun H.-Y.; Lu C.-L. |
| 臺大學術典藏 |
2020-06-18T08:26:05Z |
Prophylactic effect of lamivudine-based antiretroviral therapy on incident hepatitis B virus infection among HIV-infected patients
|
Chang S.-C.;Hung C.-C.;SUI-YUAN CHANG;Tsai M.-S.;Sun H.-Y.;Chuang Y.-C.;Sheng W.-H.; Sheng W.-H.; Chuang Y.-C.; Sun H.-Y.; Tsai M.-S.; SUI-YUAN CHANG; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:56Z |
Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review
|
Lin K.-Y.;Chen G.-J.;Lee Y.-L.;Huang Y.-C.;Cheng A.;Sun H.-Y.;Sui-Yuan Chang;Liu C.-E.;Hung C.-C.; Lin K.-Y.; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; Cheng A.; Sun H.-Y.; SUI-YUAN CHANG; Liu C.-E.; Hung C.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:56Z |
Long-term durability of responses to 2 or 3 doses of hepatitis a vaccination in human immunodeficiency virus-positive adults on antiretroviral therapy
|
Cheng A.;Sui-Yuan Chang;Sun H.-Y.;Tsai M.-S.;Liu W.-C.;Su Y.-C.;Wu P.-Y.;Hung C.-C.;Chang S.-C.; Cheng A.; SUI-YUAN CHANG; Sun H.-Y.; Tsai M.-S.; Liu W.-C.; Su Y.-C.; Wu P.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:55Z |
Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: A cross-sectional questionnaire survey
|
Lee Y.-C.;Sui-Yuan Chang;Lin K.-Y.;Chang L.-H.;Liu W.-C.;Wu C.-H.;Sun H.-Y.;Hung C.-C.;Chang S.-C.; Lee Y.-C.; SUI-YUAN CHANG; Lin K.-Y.; Chang L.-H.; Liu W.-C.; Wu C.-H.; Sun H.-Y.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:54Z |
Treatment response to unboosted atazanavir in combination with tenofovir disoproxil fumarate and lamivudine in human immunodeficiency virus-1-infected patients who have achieved virological suppression: A therapeutic drug monitoring and pharmacogenetic study
|
Tsai M.-S.;Sui-Yuan Chang;Lin S.-W.;Kuo C.-H.;Sun H.-Y.;Wu B.-R.;Tang S.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Tsai M.-S.; SUI-YUAN CHANG; Lin S.-W.; Kuo C.-H.; Sun H.-Y.; Wu B.-R.; Tang S.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:54Z |
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
|
Huang S.-H.;Lin S.-W.;Sui-Yuan Chang;Lin Y.-T.;Chiang C.;Hsiao C.-F.;Sun H.-Y.;Liu W.-C.;Su Y.-C.;Hung C.-C.;Chang S.-C.; Huang S.-H.; Lin S.-W.; SUI-YUAN CHANG; Lin Y.-T.; Chiang C.; Hsiao C.-F.; Sun H.-Y.; Liu W.-C.; Su Y.-C.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:54Z |
Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy
|
Wu U.-I.;Hung C.-C.;Sui-Yuan Chang;Jhong Y.-T.;Sun H.-Y.;Wang J.-T.;Hsieh S.-M.;Sheng W.-H.;Liu W.-C.;Chang S.-C.;Chen Y.-C.; Wu U.-I.; Hung C.-C.; SUI-YUAN CHANG; Jhong Y.-T.; Sun H.-Y.; Wang J.-T.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Chang S.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:53Z |
Dolutegravir-rilpivirine coformulation
|
Sun H.-Y.;Sui-Yuan Chang;Hung C.-C.; Sun H.-Y.; SUI-YUAN CHANG; Hung C.-C. |
| 臺大學術典藏 |
2020-06-18T08:25:53Z |
Patterns of emergent resistance-associated mutations after initiation of non-nucleoside reverse-transcriptase inhibitor-containing antiretroviral regimens in taiwan: A multicenter cohort study
|
Cheng C.-Y.;Tsai M.-S.;Yang C.-J.;Cheng S.-H.;Sun H.-Y.;Chang S.-F.;Su L.-H.;Su Y.-C.;Hung C.-C.;Sui-Yuan Chang; Cheng C.-Y.; Tsai M.-S.; Yang C.-J.; Cheng S.-H.; Sun H.-Y.; Chang S.-F.; Su L.-H.; Su Y.-C.; Hung C.-C.; SUI-YUAN CHANG |
| 臺大學術典藏 |
2020-06-18T08:25:52Z |
Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients
|
Chen G.-J.;Sun H.-Y.;Sui-Yuan Chang;Cheng A.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Su Y.-C.;Liu W.-C.;Hung C.-C.; Chen G.-J.; Sun H.-Y.; SUI-YUAN CHANG; Cheng A.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Su Y.-C.; Liu W.-C.; Hung C.-C. |
